Valuation check: AQB's ROE is -749.36%, below the Healthcare sector average of 21.28%.
Get informed when a big investor buys or sells
+ Follow-749.36%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
AquaBounty Technologies (AQB) currently reports a ROE of -749.36%. That is below the Healthcare sector average of 21.28%. Use the charts on this page to explore AquaBounty Technologies's ROE history and peer comparisons.
AquaBounty Technologies's ROE of -749.36% is lower than the Healthcare sector average of 21.28%. That is roughly 3621.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but AquaBounty Technologies's current -749.36% should be judged against Healthcare norms (sector average: 21.28%) and against AQB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -749.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.28%. From there, open related valuation or income-statement pages for AquaBounty Technologies, and consider following AQB for alerts when major investors trade the stock.
AquaBounty Technologies is classified in the Healthcare sector. On ROE, it currently shows -749.36% versus a sector average near 21.28%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AQB with unrelated industries.